Burns Matteson Capital Management’s CVS Health CVS Stock Holding History

Burns Matteson Capital Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$841K	Buy	8,131 +397	+5%	+$35.4K	0.26%	55
2026 Q1	$555K	Sell	7,734 -14	-0.2%	-$1.08K	0.2%	94
2025 Q4	$615K	Buy	+7,748	New	+$611K	0.22%	72
2024 Q3	–	Sell	-6,067	Closed	-$358K	–	172
2024 Q2	$358K	Buy	+6,067	New	+$380K	0.23%	84
2023 Q4	–	Sell	-9,747	Closed	-$681K	–	145
2023 Q3	$681K	Buy	+9,747	New	+$691K	0.43%	43
2023 Q2	–	Sell	-6,918	Closed	-$514K	–	154
2023 Q1	$514K	Sell	6,918 -32	-0.5%	-$2.68K	0.33%	91
2022 Q4	$648K	Buy	+6,950	New	+$671K	0.43%	62
2022 Q3	–	Sell	-8,587	Closed	-$796K	–	129
2022 Q2	$796K	Buy	+8,587	New	+$838K	0.56%	35
2022 Q1	–	Sell	-8,263	Closed	-$852K	–	132
2021 Q4	$852K	Buy	+8,263	New	+$764K	0.58%	42
2021 Q3	–	Sell	-5,986	Closed	-$499K	–	141
2021 Q2	$499K	Buy	5,986 +2,857	+91%	+$234K	0.4%	44
2021 Q1	$235K	Buy	+3,129	New	+$228K	0.22%	74

Other funds holding CVS

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Burns Matteson Capital Management's CVS Position: Q2 2026 in Review

Burns Matteson Capital Management increased its CVS Health (CVS) stake by 5.1% in Q2 2026, buying an estimated $35.4K and bringing the position to 8,131 shares worth $841K. The position accounts for 0.26% of the portfolio, ranked #55.

Burns Matteson Capital Management first reported a position in CVS in Q1 2021 and has held it in 11 quarters since. The position peaked at $852K in Q4 2021. 937 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Burns Matteson Capital Management held 8,131 shares of CVS Health worth $841K as of Q2 2026.
Burns Matteson Capital Management bought 397 CVS Health shares in Q2 2026, an estimated $35.4K.
CVS Health made up 0.26% of Burns Matteson Capital Management's portfolio in Q2 2026, its #55 holding.
Burns Matteson Capital Management first reported a position in CVS Health in Q1 2021 and has held it in 11 quarters since.
Burns Matteson Capital Management's CVS Health position peaked at $852K in Q4 2021.
937 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Burns Matteson Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.